This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Peter A. Cassileth, MD; Edward J. Lusk, PhD; Susan Torri, RN; Nancy DiNubile, RN; Stanton L. Gerson, MD

Arch Intern Med. 1983;143(7):1347-1349.

Abstract
• To assess the value of high-dose dexamethasone therapy in preventing the gastrointestinal (GI) side effects of chemotherapy, a randomized double-blind study was conducted in women receiving outpatient therapy for breast cancer. Single-dose dexamethasone sodium phosphate (10 mg) or placebo was administered intravenously in 57 trials in 22 women immediately before chemotherapy. Questionnaires (administered before therapy and 24 hours later) were compared for evidence of nausea, vomiting, and anorexia produced by chemotherapy. No GI Intolerance to chemotherapy was noted in 24 (83%) of the 29 dexamethasone trials v 16 (57%) of the 28 placebo trials. Dexamethasone trials produced the following results: no side effects in 50% (14/29), insomnia the night after chemotherapy in 21% (6/29), an increase in energy levels in 24% (7/29), and an improvement in mood in 14% (4/29). High-dose dexamethasone therapy has useful application in alleviating the emetic effects of cancer chemotherapy.

(Arch Intern Med 1983;143:1347-1349)

Author Affiliations
From the Hematology-Oncology Section, Department of Medicine (Drs Cassileth and Gerson and Mss Torri and DiNubile) and the Biostatistics Program of the Cancer Center (Dr Lusk), University of Pennsylvania, Philadelphia.

Footnotes
Accepted for publication Feb 28,1983.

Reprint requests to the Hospital of the University of Pennsylvania, 3400 Spruce St, Philadelphia, PA 19104 (Dr Cassileth).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Asparaginase May Influence Dexamethasone Pharmacokinetics in Acute Lymphoblastic Leukemia
Yang et al.
JCO 2008;26:1932-1939.
ABSTRACT | FULL TEXT  

Placebo-Controlled Trials
Markman
ANN INTERN MED 2001;135:63-63.
FULL TEXT  

Insomnia in the Context of Cancer: A Review of a Neglected Problem
Savard and Morin
JCO 2001;19:895-908.
ABSTRACT | FULL TEXT  

Recommendations for the Use of Antiemetics: Evidence-Based, Clinical Practice Guidelines
Gralla et al.
JCO 1999;17:2971-2971.
FULL TEXT  

Review article : Emesis in the patient with advanced cancer
Allan
Palliat Med 1988;2:89-100.
ABSTRACT  

Controlled Pilot Trial of Monthly Intravenous Cyclophosphamide in Multiple Sclerosis
Killian et al.
Arch Neurol 1988;45:27-30.
ABSTRACT  

Dexamethasone's New Use in Cancer Treatment
Berg
Journal of Pediatric Oncology Nursing 1985;2:46-48.
 

Risks in Antiemesis Using Dexamethasone
ALHASHIMI et al.
ANN INTERN MED 1984;101:281-281.
ABSTRACT  

Antiemetic Efficacy of High-Dose Dexamethasone in Induction Therapy in Acute Nonlymphocytic Leukemia
CASSILETH et al.
ANN INTERN MED 1984;100:701-702.
ABSTRACT